Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Primary Completion Date

November 30, 2009

Study Completion Date

April 30, 2010

Conditions
HIV Infections
Interventions
DRUG

Tenofovir gel

1 gm/100 ml of 1% tenofovir gel vaginally daily

DRUG

Tenofovir gel placebo

1 gm/100 ml of placebo gel vaginally daily

Trial Locations (1)

10461

Albert Einstein College of Medicine - East Campus GCRC (Herold) Non-Network CRS, The Bronx

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00594373 - Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women | Biotech Hunter | Biotech Hunter